Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jackie Palace

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
BMJ (Clinical Research Ed.)|December 4, 2009
Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparatorMike Boggild, Jackie Palace, Pelham Barton, et al.
Neuroimage|December 14, 2011
Myelin water imaging reflects clinical variability in multiple sclerosisShannon Kolind, Lucy Matthews, Heidi Johansen-Berg, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 14, 2010
Preservation of motor skill learning in patients with multiple sclerosisValentina Tomassini, Heidi Johansen-Berg, Laura Leonardi, et al.
The American Journal of Pathology|December 25, 2007
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosisJohn S Tzartos, Manuel A Friese, Matthew J Craner, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 8, 2013
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodiesJoanna Kitley, Liene Elsone, Jithin George, et al.
Brain : a Journal of Neurology|September 2, 2006
Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutationsJudy Cossins, Georgina Burke, Susan Maxwell, et al.
BMC Neurology|January 8, 2009
The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the futureMark Pickin, Cindy L Cooper, Timothy Chater, et al.
Brain : a Journal of Neurology|February 13, 2004
Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitisAngela Vincent, Camilla Buckley, Jonathan M Schott, et al.
Neuromuscular Disorders : NMD|February 1, 2020
Paediatric myasthenia gravis: Prognostic factors for drug free remissionDomizia Vecchio, Sithara Ramdas, Pinki Munot, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 21, 2014
Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UKLiene Elsone, Joanna Kitley, Sebastian Luppe, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
BMJ (Clinical Research Ed.)|December 4, 2009
Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparatorMike Boggild, Jackie Palace, Pelham Barton, et al.
Neuroimage|December 14, 2011
Myelin water imaging reflects clinical variability in multiple sclerosisShannon Kolind, Lucy Matthews, Heidi Johansen-Berg, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 14, 2010
Preservation of motor skill learning in patients with multiple sclerosisValentina Tomassini, Heidi Johansen-Berg, Laura Leonardi, et al.
The American Journal of Pathology|December 25, 2007
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosisJohn S Tzartos, Manuel A Friese, Matthew J Craner, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 8, 2013
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodiesJoanna Kitley, Liene Elsone, Jithin George, et al.
Brain : a Journal of Neurology|September 2, 2006
Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutationsJudy Cossins, Georgina Burke, Susan Maxwell, et al.
BMC Neurology|January 8, 2009
The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the futureMark Pickin, Cindy L Cooper, Timothy Chater, et al.
Brain : a Journal of Neurology|February 13, 2004
Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitisAngela Vincent, Camilla Buckley, Jonathan M Schott, et al.
Neuromuscular Disorders : NMD|February 1, 2020
Paediatric myasthenia gravis: Prognostic factors for drug free remissionDomizia Vecchio, Sithara Ramdas, Pinki Munot, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 21, 2014
Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UKLiene Elsone, Joanna Kitley, Sebastian Luppe, et al.
Pageof 3